PHARMACEUTICAL PREPARATIONS THERAPEUTIC AGENTS

Brand Owner (click to sort) Address Description
ADITXT ADITXT, INC. 737 N. 5th Street, Suite 200 Richmond VA 23219 Pharmaceutical preparations and therapeutic agents for modulating the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells to tolerize for specific antigens; pharmaceutical preparations and therapeutic agents for inducing immune tolerance;APOPTOTIC DNA IMMUNOTHERAPY TXT;Health care services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic and treatment purposes; advisory services relating to health; providing information in the field of health;Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells to tolerize for specific antigens; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research;
ADITXTREPROGRAMMING ADITXT, INC. 737 N. 5th Street, Suite 200 Richmond VA 23219 Pharmaceutical preparations and therapeutic agents modulating the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells; pharmaceutical preparations and therapeutic agents for inducing immune tolerance;ADITXT REPROGRAMING;Health care services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories; health assessment services; health monitoring services, namely, monitoring immune status of individuals for diagnostic and treatment purposes; advisory services relating to health; providing information in the field of health;Medical and clinical research and development for others in the field of immunology; medical and clinical research and development for others in the field of immunotherapies; medical and clinical research and development for others in the field of nucleic acid-based technology for selectively suppressing immune cells; medical and clinical research and development for others in the field of nucleic acid-based technology for inducing immune tolerance; consulting services in the field of immunotherapy research, transplanted tissues and organs research, and drug discovery and development; medical laboratory research; scientific research;
ADITXTSCORE ADITXT, INC. 737 N. 5th Street, Suite 200 Richmond VA 23219 Pharmaceutical preparations and therapeutic agents for modulating the immune system; pharmaceutical and therapeutic agents for use as immunotherapies; pharmaceutical preparations and therapeutic agents for selectively suppressing immune cells to tolerize for specific antigens; pharmaceutical preparations and therapeutic agents for inducing immune tolerance;ADITXT SCORE;
AVVINITY CENTAURI THERAPEUTICS LIMITED Thavies Inn House 1st Floor 3-4 Holborn Circus London EC1N2HA United Kingdom Pharmaceutical preparations and therapeutic agents for the treatment of cancer;
BETTER CELLS FOR BETTER THERAPIES Fate Therapeutics, Inc. Suite 200 3535 General Atomics Court San Diego CA 92121 Pharmaceutical preparations and therapeutic agents to modulate cell function or cell fate; reagents for clinical medical and medical use; pharmaceutical preparations and therapeutic agents for the treatment of cancer and immune disorders; pharmaceutical and therapeutic agents for use as immunotherapies;Reagents for research, drug discovery and development, and clinical laboratory use;
CABASIL STUART KABNICK PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS PREPARED IN POWDERED, LIQUID, SUPPOSITORY, CAPSULE, AND TABLET FORM-NAMELY, SURGICAL POWDER, NOSE AND THROAT POWDER, BLAND OINTMENT FOR TREATMENT OF BURNS AND MINOR SKIN CONDITIONS, CONCENTRATE OINTMENT AND LIQUID FOR USE FOR ON SLOUGHING OR GANGRENOUS TISSUES, ORAL TABLETS AND POWDER FOR STOMACH DISORDERS AND MILD INTESTINAL DISEASES, ENEMA POWDER, VAGINAL SUPPOSITORIES, RECTAL SUPPOSITORIES, FOOT POWDER, TOOTHPASTE AND ALSO MOLDED COMPOSITIONS WITH LIGATURES THEREIN FOR USE AS DEEP-SEATING IMPLANTS FOR DRAINING SINUSES, WOUNDS AND SLOW-HEALING SUTURE LINES;
CATAMARAN Catamaran Bio, Inc. 245 First Street Cambridge MA 02142 pharmaceutical preparations and therapeutic agents for the treatment of diseases and conditions, namely, cancer and immune disorders, inflammatory diseases and disorders, genetic diseases and disorders, and infectious diseases and disorders;pharmaceutical research and development; technical scientific consultation or product development for others in the fields of biotechnology, cell therapy and development of pharmaceuticals and therapeutic agents;
CEREPRO FINVECTOR VISION THERAPIES LTD OAKLEY ROAD SANDERUM HOUSE CHINNOR, OXFORDSHIRE OX39 4TW United Kingdom PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF MALIGNANT GLIOMA AND OTHER MALIGNANT BRAIN TUMORS; PHARMACEUTICAL PREPARATIONS IN THE NATURE OF VIRAL VECTORS FOR THE TREATMENT OF CANCER, CANCER VACCINES; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY(Based on 44(d) Priority Application) PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF MALIGNANT GLIOMA AND OTHER MALIGNANT BRAIN TUMORS; PHARMACEUTICAL PREPARATIONS IN THE NATURE OF VIRAL VECTORS FOR THE TREATMENT OF CANCER, CANCER VACCINES; PHARMACEUTICAL PREPARATIONS FOR USE IN CHEMOTHERAPY;
DEWPOINT Dewpoint Therapeutics, Inc. 451 D Street Boston MA 02210 Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; reagents for medical use;DEW POINT;Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use;
DEWPOINTX Dewpoint Therapeutics, Inc. 451 D Street Boston MA 02210 Pharmaceutical preparations and therapeutic agents for use in wound healing, for use in the treatment of women's health conditions in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), and for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases; reagents for medical use;DEW POINT X;
DYNO THERAPEUTICS Dyno Therapeutics, Inc. Suite 101 343 Arsenal Street Watertown MA 02472 Pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations containing adeno-associated virus (AAV) protein sequences and nucleic acid sequences for use in gene delivery; Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases;
FATE THERAPEUTICS Fate Therapeutics, Inc. Suite 200 3535 General Atomics Court San Diego CA 92121 pharmaceutical preparations and therapeutic agents to modulate cell fate; reagents for research, drug discovery and development, clinical, and medical use; and pharmaceutical preparations and therapeutic agents for the treatment of cancer;THERAPEUTICS;
REJUVENATE BIO Rejuvenate Bio Inc. 3560 Dunhill St. San Diego CA 92121 pharmaceutical preparations and therapeutic agents for use in gene therapy; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of heart disease, fibrosis, inflammation, immune dysfunction, obesity, neurodegenerative disorders, cancer, sarcopenia, joint deterioration, and for the reversal and prevention of aging; pharmaceutical preparations containing adeno-associated virus (AAV) for use in the prevention, diagnosis and treatment of heart disease, fibrosis, inflammation, immune dysfunction, obesity, neurodegenerative disorders, cancer, sarcopenia, joint deterioration, and for the reversal and prevention of aging;BIO;research and development services and technical consultation relating to the development of pharmaceuticals, gene therapies and therapeutic agents;
REJUVENATE BIO Rejuvenate Bio Inc. 3560 Dunhill St. San Diego CA 92121 pharmaceutical preparations and therapeutic agents for use in gene therapy; biologic pharmaceutical preparations for the prevention, diagnosis, and treatment of heart disease, fibrosis, inflammation, immune dysfunction, obesity, neurodegenerative disorders, cancer, sarcopenia, joint deterioration, and for the reversal and prevention of aging; pharmaceutical preparations containing adeno-associated virus (AAV) for use in the prevention, diagnosis and treatment of heart disease, fibrosis, inflammation, immune dysfunction, obesity, neurodegenerative disorders, cancer, sarcopenia, joint deterioration, and for the reversal and prevention of aging; pharmaceutical preparations for the treatment and prevention of mitral valve disease (MVD);BIO;
SOLIMA Ark Therapeutics Limited 79 New Cavendish Street London W1W 6XB United Kingdom PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS, NAMELY, PREPARATIONS OF GENES AND VECTORS FOR THERAPEUTIC PURPOSES; PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR THE TREATMENT OF BRAIN CANCER;
SYBX Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 Pharmaceutical preparations and therapeutic agents in the nature of engineered or biologically-modified microbes for the treatment of gastrointestinal diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, cancer, respiratory diseases and disorders, neurological diseases and disorders, infectious diseases and disorders, dermatological diseases and disorders, genitourinary diseases and disorders and other diseases and disorders;Assistance in business management and product commercialization; and/or advertising services, for third parties, in connection with the commercialization and sale of therapeutic products and diagnostic products, both using engineered or biologically modified microbes; Providing business consulting services in the field of therapeutic and diagnostic products, namely, assistance in product commercialization of therapeutic and diagnostic products using engineered or biologically modified microbes;Diagnostic products, namely, diagnostic preparations for clinical or medical laboratory use;Research, development and commercialization of therapeutic products using engineered or biologically modified microbes; research, development and commercialization of diagnostic products using engineered or biologically modified microbes;
SYNBIOTICS Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 Pharmaceutical preparations and therapeutic agents in the nature of engineered or biologically-modified microbes for the treatment of gastrointestinal diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, cancer, respiratory diseases and disorders, neurological diseases and disorders, infectious diseases and disorders, dermatological diseases and disorders, genitourinary diseases and disorders and other diseases and disorders;
SYNLOGIC Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 Pharmaceutical preparations and therapeutic agents in the nature of engineered or biologically-modified microbes for the treatment of gastrointestinal diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, cancer, respiratory diseases and disorders, neurological diseases and disorders, infectious diseases and disorders, dermatological diseases and disorders, genitourinary diseases and disorders and other diseases and disorders;SYN LOGIC;
SYNLOGIC Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 Pharmaceutical preparations and therapeutic agents in the nature of engineered or biologically-modified microbes for the treatment of metabolic diseases and disorders and genetic diseases and disorders;SYN LOGIC;
SYNTHETIC BIOTICS Synlogic, Inc. 301 Binney Street, Suite 402 Cambridge MA 02142 Pharmaceutical preparations and therapeutic agents in the nature of engineered or biologically-modified microbes for the treatment of gastrointestinal diseases and disorders, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, cancer, respiratory diseases and disorders, neurological diseases and disorders, infectious diseases and disorders, dermatological diseases and disorders, genitourinary diseases and disorders and other diseases and disorders;
TESSERA TESSERA THERAPEUTICS, INC. 55 Cambridge Parkway, Suite 800E Cambridge MA 02142 Pharmaceutical preparations and therapeutic agents, namely, for gene therapy and DNA editing; pharmaceutical and biological preparations based on gene, genome, and cellular editing, modulation, and modification for use in human therapeutics; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the prevention and treatment of genomic disorders;Chemical and biological agents for scientific and research use, namely, for manipulating or modifying DNA; technology for enabling the engineering and modification of DNA, namely, molecular and cellular biology reagents and assays for the modification of cells and DNA;
TRONAL Ark Therapeutics Limited 79 New Cavendish Street London W1W 6XB United Kingdom Pharmaceutical preparations and therapeutic agents for treating muscle wasting; pharmaceutical preparations and therapeutic agents for treating cancer and muscle wasting in cancer; pharmaceutical preparations and therapeutic agents for treating lipodystrophy and other metabolic conditions associated with the use of anti-HIV therapy; pharmaceutical preparations and therapeutic agents for increasing the efficiency of muscle cell energy production;TRONAL;
VISTERRA VISTERRA, INC. 275 2nd Avenue Waltham MA 02451 pharmaceutical preparations and therapeutic agents in the nature of biologics for pharmaceutical or medical purposes, for treatment of infectious diseases;
VISTERRA Parasol Therapeutics, Inc. 76 Rogers Street Cambridge MA 02142 pharmaceutical preparations and therapeutic agents in the nature of biologics for pharmaceutical or medical purposes, for treatment of infectious diseases;
VISTERRA VISTERRA, INC. 275 2nd Avenue Waltham MA 02451 Pharmaceutical preparations and therapeutic agents in the nature of biologics for pharmaceutical and medical purposes, for treatment of infectious, kidney, and inflammatory diseases;
VITOR Ark Therapeutics Limited 79 New Cavendish Street London W1W 6XB United Kingdom PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR TREATING MUSCLE WASTING; PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR TREATING CANCER AND MUSCLE WASTING IN CANCER; PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR TREATING LIPODYSTROPYY AND OTHER METABOLIC CONDITIONS ASSOCIATED WITH THE USE OF ANTI-HIV THERAPY; PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC AGENTS FOR INCREASING THE EFFICIENCY OF MUSCLE CELL ENERGY PRODUCTION;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention relates to a new and improved pharmaceutical composition and method for delivery of therapeutic agents. The methods and composition of the invention can be used with several therapeutic agents and can achieve site specific delivery of a therapeutic or diagnostic substance. This can allow for lower doses and for improved efficacy with drugs which traditionally reach targeted sites and can result in improved utility for agents such as oligonucleotides and polynucleotides which are plagued with problems with biodistribution.